HK1040114A1 - 診斷測試 - Google Patents

診斷測試

Info

Publication number
HK1040114A1
HK1040114A1 HK02101728.5A HK02101728A HK1040114A1 HK 1040114 A1 HK1040114 A1 HK 1040114A1 HK 02101728 A HK02101728 A HK 02101728A HK 1040114 A1 HK1040114 A1 HK 1040114A1
Authority
HK
Hong Kong
Prior art keywords
sub
cpla
assay
diagnostic test
type
Prior art date
Application number
HK02101728.5A
Other languages
English (en)
Inventor
Campbell Agnew Glen Alastair
John Mcdonald Donald
Original Assignee
Amarin Neuroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9905417.3A external-priority patent/GB9905417D0/en
Priority claimed from GBGB9919952.3A external-priority patent/GB9919952D0/en
Application filed by Amarin Neuroscience Ltd filed Critical Amarin Neuroscience Ltd
Publication of HK1040114A1 publication Critical patent/HK1040114A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
HK02101728.5A 1999-03-09 2002-03-06 診斷測試 HK1040114A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9905417.3A GB9905417D0 (en) 1999-03-09 1999-03-09 Diagnostic test
GBGB9919952.3A GB9919952D0 (en) 1999-08-23 1999-08-23 Diagnostic test
PCT/GB2000/000845 WO2000054052A2 (en) 1999-03-09 2000-03-08 Diagnostic test

Publications (1)

Publication Number Publication Date
HK1040114A1 true HK1040114A1 (zh) 2002-05-24

Family

ID=26315248

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101728.5A HK1040114A1 (zh) 1999-03-09 2002-03-06 診斷測試

Country Status (11)

Country Link
US (1) US7015006B1 (zh)
EP (1) EP1159616B1 (zh)
JP (1) JP2002539430A (zh)
KR (1) KR20010102351A (zh)
AT (1) ATE306667T1 (zh)
AU (1) AU766559B2 (zh)
CA (1) CA2365973A1 (zh)
DE (1) DE60023121T2 (zh)
HK (1) HK1040114A1 (zh)
NZ (1) NZ512768A (zh)
WO (1) WO2000054052A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3507884B2 (ja) * 2000-03-07 2004-03-15 新潟大学長 遺伝子発現を指標とする統合失調症の客観的診断法
KR20040001144A (ko) * 2002-06-27 2004-01-07 김대경 신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
KR100500260B1 (ko) * 2002-07-31 2005-07-11 김대경 소의 뇌에서의 세포질형 포스포리파아제 에이 투 효소를활성화시키는 신규의 단백질, 이의 용도 및 제조 방법
GB2415039B (en) 2004-06-11 2008-11-12 Johnson & Johnson Medical Ltd Diagnosis and prognosis
WO2005121357A2 (en) * 2004-06-11 2005-12-22 Ethicon, Inc. Diagnosis and prognosis of wound infection by measurement of a phospholipase a2 in wound fluid
WO2007050318A2 (en) * 2005-10-24 2007-05-03 Duke University Lipidomics approaches for central nervous system disorders
US8137977B2 (en) * 2006-04-24 2012-03-20 Children's Hospital & Research Center At Oakland Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
DE102007022669A1 (de) 2007-05-11 2008-11-20 Carsten Dr. Korth Verwendung von CRMP1 als Marker für chronisch psychiatrische Erkrankungen
DE102008016064A1 (de) 2008-03-26 2009-10-01 Carsten Dr. Korth Verfahren zur Diagnose und Behandlung von chronisch psychiatrischen Erkrankungen sowie Marker und Targets für solche Verfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622832A (en) * 1990-02-28 1997-04-22 Genetics Institute, Inc. Arachidonic acid releasing phospholipase A2 enzyme and methods of use
CA2049482A1 (en) 1990-08-24 1992-02-25 Ruth M. Kramer Human cytosolic phospholipase a2
RU2009509C1 (ru) 1991-04-29 1994-03-15 Свердловский научно-исследовательский кожно-венерологический институт Способ прогнозирования течения псориаза
US5279957A (en) * 1992-04-30 1994-01-18 Washington University cDNA encoding human phospholipase A2 polypeptide
US5327698A (en) * 1992-10-14 1994-07-12 Century Industries, Inc. Mobile erectable stage and sound shell

Also Published As

Publication number Publication date
CA2365973A1 (en) 2000-09-14
JP2002539430A (ja) 2002-11-19
DE60023121D1 (de) 2006-02-23
EP1159616A2 (en) 2001-12-05
EP1159616B1 (en) 2005-10-12
WO2000054052A2 (en) 2000-09-14
AU2931000A (en) 2000-09-28
KR20010102351A (ko) 2001-11-15
NZ512768A (en) 2004-02-27
US7015006B1 (en) 2006-03-21
ATE306667T1 (de) 2005-10-15
AU766559B2 (en) 2003-10-16
WO2000054052A3 (en) 2000-12-21
DE60023121T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
US20170267740A1 (en) Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis
Chechik et al. An immunomorphologic study of adenosine deaminase distribution in human thymus tissue, normal lymphocytes, and hematopoietic cell lines.
DE69621953D1 (de) Vehikel zum einbringen von nukleinsäuren in zellen
US5641636A (en) Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
HK1040114A1 (zh) 診斷測試
DK107391A (da) Isolering af foetale celler fra moderblod for at muliggoere diagnose foer foedslen
ES8609472A1 (es) Una sonda de deteccion de acidos nucleicos
WO2002014537A3 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
Cervera et al. Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.
EP2357478A3 (en) Diagnosis of disease
EP0353985A3 (en) Nucleic acid probe for detection of neisseria gonorrhoea
RU96115937A (ru) Новые пептиды, являющиеся производными аутоантигена, предназначенные для использования в иммунотерапии аутоиммунных заболеваний
TR200103011T2 (tr) Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.
ES2078733T3 (es) Metodo para la deteccion de anticuerpos anti-arn.
Pittaway et al. Serum CA-125 in the evaluation of benign adnexal cysts
ATE382678T1 (de) Verfahren zur diagnose von rickettsia pulicis
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
Beachy et al. Lectins activate lymphocyte pyruvate dehydrogenase by a mechanism sensitive to protease inhibitors.
Ignjatović et al. Biochemical evaluation of patients with acute pancreatitis
BR9909308A (pt) Peptìdeo, ensaio para o diagnóstico de esquizofrenia em um indivìduo, e, kit para uso no diagnóstico de esquizofrenia
Malfertheiner et al. Diagnosis and staging of acute pancreatitis
Thomas et al. Effects of metalloendoprotease substrates on the human sperm acrosome reaction
RU95122204A (ru) Способ диагностики внутреннего эндометриоза матки
Guitart et al. Diffuse Dermal Histiocytosis A Variant of Generalized Granuloma Annulare
EP1398378A4 (en) IN NEUROBLASTOM ISOLATED NUCLEIC ACIDS

Legal Events

Date Code Title Description
CHRG Changes in the register